AI assistant
Sending…
BIODESIX INC — Director's Dealing 2023
Aug 7, 2023
34472_dirs_2023-08-07_f3f95101-3fd6-44d5-9ccb-42d90d4874b0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-08-03
Reporting Person: Kennedy Lawrence T. Jr (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Common Stock | A | 6172839 | $1.62 | Acquired | 10528753 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9582783 | Indirect |
| Common Stock | 166666 | Indirect |
| Common Stock | 722041 | Indirect |
Footnotes
F1: Reported amounts have been adjusted to reflect the March 13, 2023 transfer of 433,894 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.
More from BIODESIX INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23